John Davis, MD
Otolaryngology · Hoover, ALNPI 1124113501
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $159,473 of the $250,843 with a category attached, or 63.6%. 25 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 26.4% of the total. 2025 is the largest year on record at $83,085, more than ten times the $411 reported in 2019. Among otolaryngology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 420 payments — averaging $597.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$66K
- Sanofi$55K
- Aerin Medical Inc.$52K
- GSK$47K
- Intersect ENT, Inc.$12K
- Spirair, Inc.$11K
- plus $7K from 19 others
Across 97 payments — averaging $1439.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neurent Medical Limited$46K
- Aerin Medical Inc.$35K
- Regeneron$35K
- Sanofi US Services Inc.$24K
What the payments were for
- Consulting fees$63,99526%
- Speaking & faculty fees$159,47364%
- Travel & lodging$16,3827%
- Food & beverage$10,8944%
- Education$980%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 69 | $66,266 |
| Sanofi | 65 | $55,379 |
| Aerin Medical Inc. | 68 | $52,170 |
| GSK | 86 | $47,291 |
| Intersect ENT, Inc. | 12 | $12,044 |
| Spirair, Inc. | 4 | $10,726 |
| Regeneron | 3 | $4,447 |
| Optinose US, Inc. | 48 | $770 |
| Inspire Medical Systems, Inc. | 2 | $251 |
| Aroa Biosurgery Incorporated | 5 | $240 |
| Medtronic | 3 | $217 |
| AbbVie | 10 | $204 |
| Boston Scientific | 21 | $203 |
| AstraZeneca | 2 | $143 |
| Alk-abello, Inc | 2 | $79 |
| Integra Lifesciences Corporation | 3 | $73 |
| KARL Storz Endoscopy-america | 2 | $68 |
| Amgen | 3 | $67 |
| Stryker | 4 | $54 |
| Pentax Of America, Inc. | 2 | $41 |
| Merck | 2 | $41 |
| Baxter Healthcare | 1 | $22 |
| Genentech USA, Inc. | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Olympus America Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$121,889
- VIVAER STYLUS$50,967
- NUCALA$45,867
- SeptAlign$21,301
- TURBALIGN$18,901
- RHINAER STYLUS$605
- PROPEL$478
- Inspire$251
- TEZSPIRE$122
How this compares
$250,843 in reported general payments places this provider in the 95th percentile of 155 otolaryngology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 12 | $44,296 |
| Dexlansoprazole DrDexlansoprazole | 35 | $9,779 |
| Omeprazole | 136 | $1,878 |
| Ipratropium Bromide | 60 | $1,745 |
| Azelastine Hcl | 43 | $1,061 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 72 | $785 |
| Esomeprazole Magnesium | 12 | $782 |
| Pantoprazole Sodium | 47 | $733 |
| Cefdinir | 29 | $683 |
| Montelukast Sodium | 58 | $580 |
| Ondansetron OdtOndansetron | 38 | $446 |
| Ofloxacin | 11 | $444 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $391 |
| Famotidine | 24 | $306 |
| Prednisone | 76 | $269 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Hoover
- William McFeelyHuntsville$70K
- Michael SillersBirmingham$53K
- Justin TurnerBirmingham$34K
- Bradford WoodworthBirmingham$27K
- Patrick OwensBirmingham$26K
- Kirk WithrowBirmingham$22K
- Do-Yeon ChoBirmingham$19K
- William BlytheOpelika$19K
- Andrew FusonBirmingham$18K
- John KostrzewaHuntsville$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.